These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1689701)

  • 21. Characterization of an RTX toxin from enterohemorrhagic Escherichia coli O157:H7.
    Bauer ME; Welch RA
    Infect Immun; 1996 Jan; 64(1):167-75. PubMed ID: 8557336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Convergent Evolution of Neutralizing Antibodies to Staphylococcus aureus γ-Hemolysin C That Recognize an Immunodominant Primary Sequence-Dependent B-Cell Epitope.
    Hernandez DN; Tam K; Shopsin B; Radke EE; Law K; Cardozo T; Torres VJ; Silverman GJ
    mBio; 2020 Jun; 11(3):. PubMed ID: 32546616
    [No Abstract]   [Full Text] [Related]  

  • 23. Production and characterization of monoclonal antibodies against Staphylococcus aureus alpha-toxin.
    Blomqvist L; Sjögren A
    Toxicon; 1988; 26(3):265-73. PubMed ID: 3394159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isoleucine 61 is important for the hemolytic activity of pyolysin of Trueperella pyogenes.
    Yan M; Hu Y; Bao J; Xiao Y; Zhang Y; Yang L; Wang J; Zhang W
    Vet Microbiol; 2016 Jan; 182():196-201. PubMed ID: 26711048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The production of HlyA toxin by Proteus penneri strains.
    Senior BW
    J Med Microbiol; 1993 Oct; 39(4):282-9. PubMed ID: 8411089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibody-defined epitope map of expressed rubella virus protein domains.
    Wolinsky JS; McCarthy M; Allen-Cannady O; Moore WT; Jin R; Cao SN; Lovett A; Simmons D
    J Virol; 1991 Aug; 65(8):3986-94. PubMed ID: 1712855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional replacement of the hemolysin A transport signal by a different primary sequence.
    Zhang F; Greig DI; Ling V
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4211-5. PubMed ID: 8483936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity of Actinobacillus ApxIA toxin epitopes fused to the E. coli heat-labile enterotoxin B subunit.
    Bagdasarian MM; Nagai M; Frey J; Bagdasarian M
    Vaccine; 1999 Feb; 17(5):441-7. PubMed ID: 10073721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of amino acid substitutions in the epitope regions of pyolysin from Arcanobacterium pyogenes.
    Imaizumi K; Matsunaga K; Higuchi H; Kaidoh T; Takeuchi S
    Vet Microbiol; 2003 Feb; 91(2-3):205-13. PubMed ID: 12458169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutralization of hemolytic and mouse lethal activities of C. perfringens alpha-toxin need simultaneous blockade of two epitopes by monoclonal antibodies.
    Schoepe H; Wieler LH; Bauerfeind R; Schlapp T; Potschka H; Hehnen HR; Baljer G
    Microb Pathog; 1997 Jul; 23(1):1-10. PubMed ID: 9250775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Location of the Bombyx mori aminopeptidase N type 1 binding site on Bacillus thuringiensis Cry1Aa toxin.
    Atsumi S; Mizuno E; Hara H; Nakanishi K; Kitami M; Miura N; Tabunoki H; Watanabe A; Sato R
    Appl Environ Microbiol; 2005 Jul; 71(7):3966-77. PubMed ID: 16000811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of epitopes involved in the neutralization of Pasteurella haemolytica serotype A1 leukotoxin.
    Lainson FA; Murray J; Davies RC; Donachie W
    Microbiology (Reading); 1996 Sep; 142 ( Pt 9)():2499-507. PubMed ID: 8828217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active and inactive forms of hemolysin (HlyA) from Escherichia coli.
    Wagner W; Kuhn M; Goebel W
    Biol Chem Hoppe Seyler; 1988 Jan; 369(1):39-46. PubMed ID: 3279976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli.
    Bckström M; Holmgren J; Schödel F; Lebens M
    Gene; 1995 Nov; 165(2):163-71. PubMed ID: 8522171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the in vivo activation of hemolysin (HlyA) from Escherichia coli.
    Ludwig A; Garcia F; Bauer S; Jarchau T; Benz R; Hoppe J; Goebel W
    J Bacteriol; 1996 Sep; 178(18):5422-30. PubMed ID: 8808931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vibrio cholerae HlyA hemolysin is processed by proteolysis.
    Hall RH; Drasar BS
    Infect Immun; 1990 Oct; 58(10):3375-9. PubMed ID: 2205579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A heterologous membrane protein domain fused to the C-terminal ATP-binding domain of HlyB can export Escherichia coli hemolysin.
    Thomas WD; Wagner SP; Welch RA
    J Bacteriol; 1992 Nov; 174(21):6771-9. PubMed ID: 1400227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acylation of Escherichia coli hemolysin: a unique protein lipidation mechanism underlying toxin function.
    Stanley P; Koronakis V; Hughes C
    Microbiol Mol Biol Rev; 1998 Jun; 62(2):309-33. PubMed ID: 9618444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of functional domains of Vibrio parahaemolyticus thermostable direct hemolysin using monoclonal antibodies.
    Tang G; Iida T; Yamamoto K; Honda T
    FEMS Microbiol Lett; 1997 May; 150(2):289-96. PubMed ID: 9170273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain.
    Ryan ET; Butterton JR; Smith RN; Carroll PA; Crean TI; Calderwood SB
    Infect Immun; 1997 Jul; 65(7):2941-9. PubMed ID: 9199470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.